CONMED Corporation (CNMD)

Debt-to-capital ratio

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Long-term debt US$ in thousands 780,689 796,148 803,555
Total stockholders’ equity US$ in thousands 834,222 796,205 780,194 752,453 745,545 716,337 672,968 789,546 785,435 755,683 744,499 725,570 709,038 683,141 674,898 701,635 710,467 700,922 697,009 693,057
Debt-to-capital ratio 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.53 0.53 0.54

December 31, 2023 calculation

Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $—K ÷ ($—K + $834,222K)
= 0.00

The debt-to-capital ratio of Conmed Corp. has fluctuated over the past eight quarters, ranging from 0.48 to 0.59. This ratio indicates the extent to which the company relies on debt financing as opposed to equity financing.

The increasing trend in the debt-to-capital ratio from Q1 2022 to Q1 2023 suggests an increasing reliance on debt to finance its operations and growth initiatives. However, it is worth noting that the ratio decreased slightly in Q4 2023, indicating a potential shift towards a more balanced mix of debt and equity in the capital structure.

A higher debt-to-capital ratio may signal increased financial risk and potential difficulties in meeting debt obligations, especially during economic downturns or financial constraints. Conversely, a lower ratio may indicate a more conservative approach to financing, potentially limiting growth opportunities.

Overall, the fluctuating debt-to-capital ratio of Conmed Corp. suggests a dynamic capital structure management strategy, which should be closely monitored to ensure sustainable financial health and long-term stability.


Peer comparison

Dec 31, 2023